Cyclical Combination Chemotherapy in Advanced Breast Cancer

Results with cyclical combination chemotherapy in advanced breast cancer are presented. The overall remission rate, 79 per cent, is superior to that obtained by two conventional endocrine procedures, administration of norethisterone acetate and hypophysectomy. The advantage is especially pronounced...

Descripción completa

Detalles Bibliográficos
Autores principales: Edelstyn, G. A., Macrae, K. D.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1973
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008915/
https://www.ncbi.nlm.nih.gov/pubmed/4758373
_version_ 1782136010260348928
author Edelstyn, G. A.
Macrae, K. D.
author_facet Edelstyn, G. A.
Macrae, K. D.
author_sort Edelstyn, G. A.
collection PubMed
description Results with cyclical combination chemotherapy in advanced breast cancer are presented. The overall remission rate, 79 per cent, is superior to that obtained by two conventional endocrine procedures, administration of norethisterone acetate and hypophysectomy. The advantage is especially pronounced in patients with visceral deposits.
format Text
id pubmed-2008915
institution National Center for Biotechnology Information
language English
publishDate 1973
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20089152009-09-10 Cyclical Combination Chemotherapy in Advanced Breast Cancer Edelstyn, G. A. Macrae, K. D. Br J Cancer Articles Results with cyclical combination chemotherapy in advanced breast cancer are presented. The overall remission rate, 79 per cent, is superior to that obtained by two conventional endocrine procedures, administration of norethisterone acetate and hypophysectomy. The advantage is especially pronounced in patients with visceral deposits. Nature Publishing Group 1973-11 /pmc/articles/PMC2008915/ /pubmed/4758373 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Articles
Edelstyn, G. A.
Macrae, K. D.
Cyclical Combination Chemotherapy in Advanced Breast Cancer
title Cyclical Combination Chemotherapy in Advanced Breast Cancer
title_full Cyclical Combination Chemotherapy in Advanced Breast Cancer
title_fullStr Cyclical Combination Chemotherapy in Advanced Breast Cancer
title_full_unstemmed Cyclical Combination Chemotherapy in Advanced Breast Cancer
title_short Cyclical Combination Chemotherapy in Advanced Breast Cancer
title_sort cyclical combination chemotherapy in advanced breast cancer
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008915/
https://www.ncbi.nlm.nih.gov/pubmed/4758373
work_keys_str_mv AT edelstynga cyclicalcombinationchemotherapyinadvancedbreastcancer
AT macraekd cyclicalcombinationchemotherapyinadvancedbreastcancer

Ejemplares similares